Vitamin D receptor induces oxidative stress to promote esophageal squamous cell carcinoma proliferation via the p53 signaling pathway

被引:4
|
作者
Shang, Qi-Xin [1 ]
Zhang, Han -Lu [1 ]
Cheng, Ya-Ping [2 ]
Lu, Han [2 ]
Yuan, Yong [1 ]
Chen, Long-Qi [1 ]
Ji, Ai -Fang [2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Thorac Surg, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China
[2] Changzhi Med Univ, Heping Hosp, 161 Jiefang East St, Changzhi 046000, Peoples R China
关键词
Esophageal squamous cell carcinoma; VDR; Cell phenotype; TMT proteomics; p53 signaling pathway; Oxidative stress; Tumor formation in nude mice; COLON-CANCER; PROSTATE-CANCER; EXPRESSION; GENE; ASSOCIATION; POLYMORPHISM; METABOLISM; CALCIUM; GENOME; TISSUE;
D O I
10.1016/j.heliyon.2023.e23832
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Esophageal squamous cell carcinoma (ESCC) is a common pathological esophageal cancer with poor prognosis. Vitamin D deficiency reportedly occurs in ESCC patients, and this is related to single nucleotide polymorphism of vitamin D receptor (VDR).Objective: We investigated the effect of VDR on ESCC proliferation, invasion, and metastasis and its potential mechanism.Methods: ESCC and normal tissues were collected from 20 ESCC patients. The ESCC tissue microarray contained 116 pairs of ESCC and normal tissues and 73 single ESCC tissues. VDR expression and its clinicopathological role were determined by real-time quantitative polymerase chain reaction, Western blot, and immunohistochemistry staining. sh-VDR and VDR over-expression were used to validate the effect of VDR on ESCC cell phenotype, and tandem mass tag-based quantitative proteomics and bioinformatics methods identified differential VDR-related proteins. The downstream pathway and regulatory effect were analyzed using ingenuity pathway analysis (IPA). Differentially expressed proteins were verified through parallel reaction monitoring and Western blot. In vivo imaging visualized subcutaneous tumor growth following tail vein injection of VDR-deficient ESCC cells.Results: High VDR expression was observed in ESCC tissues and cells. Gender, T stage, and TNM stage were related to VDR expression, which was the independent prognostic factor related to ESCC. VDR downregulation repressed ESCC cell proliferation, invasion, and migration in vitro and subcutaneous tumor growth and lung metastases in vivo. The cell phenotype changes were reversed upon VDR upregulation, and differential proteins were mainly enriched in the p53 signaling pathway. TP53 cooperated with ABCG2, APOE, FTH1, GCLM, GPX1, HMOX1, JUN, PRDX5, and SOD2 and may activate apoptosis and inhibit oxidative stress, cell metastasis, and proliferation. TP53 was upregulated after VDR knockdown, and TP53 downregulation reversed VDR knockdown-induced cell phenotype changes.Conclusions: VDR may inhibit p53 signaling pathway activation and induce ESCC proliferation, invasion, and metastasis by activating oxidative stress.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway
    Xu, Nana
    Lu, Mengmeng
    Wang, Jiaxin
    Li, Yujia
    Yang, Xiaotian
    Wei, Xiajie
    Si, Jiaoyang
    Han, Jingru
    Yao, Xiaojuan
    Zhang, Juanmei
    Liu, Junqi
    Li, Yanming
    Yang, Hushan
    Bao, Dengke
    BMC CANCER, 2021, 21 (01)
  • [22] p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma
    Asuka Murata
    Yoshifumi Baba
    Masayuki Watanabe
    Hironobu Shigaki
    Keisuke Miyake
    Ryuichi Karashima
    Yu Imamura
    Satoshi Ida
    Takatsugu Ishimoto
    Shiro Iwagami
    Yasuo Sakamoto
    Yuji Miyamoto
    Naoya Yoshida
    Hideo Baba
    Medical Oncology, 2013, 30
  • [23] p53 protein immunoexpression in esophageal squamous cell carcinoma and adjacent epithelium
    Chaves, P
    Pereira, AD
    Pinto, A
    Oliveira, AG
    Queimado, L
    Gloria, L
    Cardoso, P
    Mira, FC
    Soares, J
    JOURNAL OF SURGICAL ONCOLOGY, 1997, 65 (01) : 3 - 9
  • [24] P53 codon 72 polymorphism and the risk of esophageal squamous cell carcinoma
    Yang, Wenjun
    Zhang, Yanyan
    Tian, Xiuyun
    Ning, Tao
    Ke, Yang
    MOLECULAR CARCINOGENESIS, 2008, 47 (02) : 100 - 104
  • [25] Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma
    Yao, Wenjian
    Qin, Xiuguang
    Qi, Bo
    Lu, Jianguo
    Guo, Ling
    Liu, Fulei
    Liu, Shangguo
    Zhao, Baosheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (10): : 7158 - 7163
  • [26] p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma
    Shimada, Hideaki
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2018, 2 (04): : 266 - 273
  • [27] p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma
    Murata, Asuka
    Baba, Yoshifumi
    Watanabe, Masayuki
    Shigaki, Hironobu
    Miyake, Keisuke
    Karashima, Ryuichi
    Imamura, Yu
    Ida, Satoshi
    Ishimoto, Takatsugu
    Iwagami, Shiro
    Sakamoto, Yasuo
    Miyamoto, Yuji
    Yoshida, Naoya
    Baba, Hideo
    MEDICAL ONCOLOGY, 2013, 30 (04)
  • [28] Betulinic Acid Inhibits Cell Proliferation in Human Oral Squamous Cell Carcinoma via Modulating ROS-Regulated p53 Signaling
    Shen, Huan
    Liu, Li
    Yang, Yongjin
    Xun, Wenxing
    Wei, Kewen
    Zeng, Guang
    ONCOLOGY RESEARCH, 2017, 25 (07) : 1141 - 1152
  • [29] Donafenib activates the p53 signaling pathway in hepatocellular carcinoma, induces ferroptosis, and enhances cell apoptosis
    Liang, Jiaming
    Chen, Meifeng
    Yan, Guohong
    Hoa, Pham Thi Thai
    Wei, Shuxin
    Huang, Hailian
    Xie, Qichong
    Luo, Xiaoling
    Mo, Shutian
    Han, Chuangye
    CLINICAL AND EXPERIMENTAL MEDICINE, 2025, 25 (01)
  • [30] p53 Expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma
    Hirvikoski, P
    Kumpulainen, E
    Virtaniemi, J
    Johansson, R
    Haapasalo, H
    Marin, S
    Halonen, P
    Helin, H
    Raitiola, H
    Pukander, J
    KellokumpuLehtinen, P
    Kosma, VM
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (09) : 3111 - 3120